Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction

Interview with Divaka Perera, MA, MD, author of Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial, and Julio A. Panza, MD, author of Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive. Hosted by James E. Udelson, MD. Related Content: Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive

You can listen to Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction online on Radio and Podcast. Open the player on this page to stream the available audio.

Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction is an episode from JAMA Cardiology Author Interviews: Covering research in cardiovascular medicine, science, & clinical practice. For physicians, researchers, & clinicians by American Medical Association.

This episode is 20:58 long.

This episode was published on Oct 25, 2023.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from JAMA Cardiology Author Interviews: Covering research in cardiovascular medicine, science, & clinical practice. For physicians, researchers, & clinicians when more episodes are available from the podcast feed.